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NURSE-DELIVERED STANDARDIZED CHEMOTHERAPY
Abstract
Background/Review of Literature: A new cancer diagnosis is overwhelming and stressful. A
multitude of information will be shared, and treatment initiated quickly. To prepare patients for
chemotherapy, a comprehensive and systematic education program should be utilized.
Combining written instructions and supportive material with nurse-led teaching sessions have
been found to be most beneficial. Well prepared patients have been shown to have less anxiety,
more confidence to handle adverse effects at home, and improved quality of life. Purpose: The
quality improvement (QI) project purpose was to explore the effect of a nurse-delivered,
enhanced education intervention on distress among older adults receiving chemotherapy in an
outpatient setting. Design/Methods: The enhanced chemotherapy education intervention
consisted of a 1-hour educational class facilitated by an oncology nurse, PowerPoint
presentation, and written materials. A quasi-experimental, pretest-posttest design was used to
compare outcomes across two groups of patients. Procedures: Group 1 received whatever prechemotherapy educational materials usually offered to patients by the unit (usual care). Group 2
received enhanced educational intervention prior to their first cycle of treatment. Both groups
completed a Distress Thermometer and Problem List prior to Cycle 1, and prior to Cycle 2. All
participants completed an investigator-designed patient satisfaction survey.
Results/Interpretation: Both groups reported less distress prior to Cycle 2. Group 2 reported
higher satisfaction scores (100% vs. 89%), called/came to office with fewer concerns (2 vs. 7),
and fewer Emergency Room and hospital visits (1 vs. 2). The QI project resulted in improved
patient satisfaction, decreased need for intervention with side effects, and fewer hospital visits
among adult cancer patients receiving chemotherapy in an outpatient community setting.
Keywords: chemotherapy education, distress, quality of life, nurse-led
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Nurse-delivered Standardized Chemotherapy Education Intervention to Reduce Distress among
Older Adults in an Outpatient Setting
A diagnosis of cancer is a life-altering event. Treatment plans are made and patients are
quickly thrown into a new world of chemotherapy, side effects, and managing complicated
medications at home (Apor et al., 2018; Garcia, 2014; Mollaoglu & Erdogan, 2014; Sahin &
Erguney, 2015; Sahin, Erguney, Sahin, & Erguney, 2016; Yuce & Yurtsever, 2017). While
anxiety can never be completely resolved, it can be reduced through empowering patients and
their caregivers with relevant evidence-based education and resources. Walking into a chemo
room for the first time can be emotional and overwhelming for a patient. Education given before
the first administration of chemotherapy has been shown to reduce this anxiety and lead to better
quality of life.
Background
According to estimates by the American Cancer Society (ACS), over 1.8 million people
in the United States will be diagnosed with cancer in the year 2020 (ACS, 2019). This represents
a staggering 4,950 new cases of cancer per day (Siegel, Miller, & Jemal, 2020). Although the 5year survival rate for cancer is improving, cancer remains the leading cause of death and is
expected to rise over the next 10 years to over 23 million worldwide (National Cancer Institute
[NCI], 2018). The Centers for Disease Control and Prevention (CDC) estimated in 2018 that
650,000 patients will receive chemotherapy annually (CDC, 2018).
Lack of quality educational resources for patients prior to initiating treatment can lead to
them being poorly equipped to handle side effects and increase their anxiety and distress. In
accordance with the six quality-dimension initiatives recommended by the Institute of Medicine
(IOM), a safe and patient-centered approach should be utilized when delivering care (Agency for
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Healthcare Research and Quality [AHRQ], 2016). Minimum recommendations made by the
American Society for Clinical Oncology (ASCO) guidelines include providing verbal and
written education to patients prior to the first treatment. This education should include basic
medical information, supportive care, contact information, and involve family (Neuss et al.,
2017).
The problem of incomplete pre-chemotherapy education is significant on a local level as
not all patients who are scheduled to begin chemotherapy are being provided complete
educational preparation. Empowering patients with tools to manage adverse effects supports
competence and when done early in diagnosis can decrease anxiety and stress levels
(Papadopoulou et al., 2017). Patients who are not provided education using a standardized
approach can be missing key information regarding the complexities of chemotherapy
administration.
Problem Statement
When newly diagnosed adult cancer patients (>18 years); are not adequately informed
and prepared to receive chemotherapy treatments prior to the first time they enter the infusion
center, they often experience more distress and anxiety than they already have. This state can
lead to increased adverse effects such as nausea, vomiting, and dehydration and is influenced by
not having had quality, literacy appropriate, and standardized pretreatment chemotherapy
education.
Organizational “Gap” Analysis of Project Site
Lack of education prior to treatment can lead to increased anxiety and side effects,
ultimately decreasing the quality of life in cancer patients (Apor et al., 2018; Garcia, 2014;
Mollaoglu & Erdogan, 2014; Sahin & Erguney, 2015; Sahin, Erguney, Sahin, & Erguney, 2016;
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Yuce & Yurtsever, 2017). Furthermore, standardization of educational processes can lead to
improved nursing satisfaction, improved efficacy of staff time, and improved quality of care
(Gallegos et al., 2019). The site used for this QI project is a physician-owned private practice
located in Central Florida. Permission by the organization was obtained and can be found in
Appendix A. At the time of the QI project, this office had seven physicians and eight nurse
practitioners. There is a large volume of patients each week in the infusion room. Approximately
300–350 patients per week receive chemotherapy or other intravenous treatments there, and
approximately ten of those are starting chemotherapy for the first time. The chemotherapy room
contains 30 chairs. Not all patients were getting education prior to starting chemotherapy; some
were unsure what to expect or how to manage their side effects. This uncertainty can lead to a
worsening of common adverse effects such as nausea and vomiting as well as not seeking
prompt treatment for serious side effects related to neutropenia.
The charge nurse is responsible to provide a brief verbal educational session. Materials
are printed by the nursing staff from a variety of online sources and placed in a binder. It was
difficult to track in a definitive way the number of patients missing the educational class or
missing key information and resources. Printed materials were not verified by practitioners for
health literacy or appropriateness. There was no uniformity for patient education between
different offices in the practice. The practice’s website had many valuable educational resources
available; however, there was not one for general prechemotherapy orientation. Over 100 offices
are part of this practice and, while some locations had been improving on the educational
processes, there was no uniform policy. When patients and caregivers do not get adequate
education and knowledge to provide care at home, it can lead to increased anxiety and ineffective
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care (Garcia, 2014). Therefore, the goal of the QI project was to establish a model that will
standardize the education program used for all new cancer patients at all locations in the practice.
Review of the Literature
Search Methods
An extensive literature search was completed, including the following databases: Current
Index to Nursing Allied Health Literature Complete (CINAHL), PubMed, Google Scholar,
Cochrane Library, and Ovid. All searches were limited to articles during 2013–2019, in the
English language, peer reviewed, and research articles. CINAHL was searched using the terms
chemotherapy education or chemotherapy education for newly diagnosed cancer patients or prechemotherapy education or prechemotherapy education. The search was limited to age groups
19+. This yielded 111 articles with 91 excluded at the title. A total of 20 articles were given
complete review. One was excluded as it focused on patient beliefs about treatment, one was a
duplicate of a PubMed article, one was specific to neuropathy, one was excluded for not being a
pretreatment intervention, one was coping strategies without intervention, one covered chemo
administration, and finally four were specific to oral chemotherapy. Nine articles were selected
and included in this review.
PubMed and Cochrane were searched using Medical Subject Headings (MeSH) terms
antineoplastic therapy and patient education, excluded for oral chemotherapy. Articles were
limited to adults. Cochrane yielded zero articles. PubMed yielded 132 articles, 99 were excluded
at title, 21 were excluded at abstract review, and 12 required full review. Two were excluded for
small sample size, one was not a study, four were not pretreatment, one was about implanted
ports, one was specific to drug adherence, and one was a review of older literature. Two articles
remain included in this review.
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Google Scholar was searched using terms “prechemotherapy education for patients”
excluded for term oral, yielded 945 articles. The search terms were narrowed to the phrase
“chemotherapy education,” yielding 30 articles. Five were included for complete review after
excluding 25 duplicates from other databases or in this search. One was an abstract of an article
already included, one was a review, one had small sample sizes, one was specific to goals that
yielded one article for this review. The Ovid database was searched for keywords chemo*
education or prechemo* education or pre-chemo* education and patient education yielding four
articles. Three were excluded for being oral treatments, and one was specific for symptom
control, leaving zero.
Search Results
The 12 articles were appraised using the MeInyk Levels of Evidence (Melnyk & FineoutOverholt, 2011). Quality of the evidence was rated using the Johns Hopkins Nursing EvidenceBased Practice Quality of Evidence Rating Scale (Poe & White, 2010). The 12 articles in this
review include one randomized controlled trial, six quasi-experimental articles, one integrative
review, one longitudinal study, and two non-experimental studies. The Appraisal of Guidelines
for Research and Evaluation (AGREE II; Brouwers et al., 2010) was used for scoring ASCO
guidelines. A matrix of this data can be found in Appendix B.
Evidence-Based Interventions
The evidence supports the use of patient education prior to the first chemotherapy. All
but one of the 12 studies used education prior to the first chemo. The intervention of a DVD was
utilized by Milanti, Metsala, and Hannula (2016), which was shown during the actual
administration of chemotherapy. Several studies used multiple educational sessions with the first
session prior to the first chemo (Gallegos et al., 2019; Mollaoglu & Erdogan, 2014; Sahin &
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Erguney, 2015; Sahin, Erguney, Sahin, & Erguney, 2016). Furthermore, this recommendation is
supported in the updated ASCO guidelines in collaboration with the Oncology Nursing Society
(ONS) as part of the safe administration of chemotherapy (Neuss et al., 2017). All studies
concluded that education prior to the first chemo was beneficial; however, there was also one
report of improved quality of life when the education occurred during the chemotherapy (Milanti
et al., 2016). There was no supporting study that suggested multiple educational sessions are
better than a single session.
All studies in which a verbal educational session was used support the use of a nurse as
the educator. According to Garcia’s review (2014), this is a “consistent theme throughout the
literature” (p. 520). The role of nurse as educator is described by (Milanti et al., 2016) as one that
is unique because nurses play an important role in psychosocial interventions. It is further
suggested by Apor et al. (2018) that even when the oncologist provides some education about
chemotherapy, they were also discussing diagnosis and prognosis and not focused on specifics of
treatment. When asked about their knowledge after having met with the oncologist, patients had
zero or little information about potential adverse effects or scheduling of treatments. One study
(Gallegos et al., 2019) that was designed slightly differently used one-on-one nurse-led teaching,
and the group-led class was done by a pharmacist. Nursing implications recommended by
Papadopoulou et al. (2017) suggest that use of education by nurses can lead to patients’ increased
perception of self-care strategies and can be expected to reduce anxiety.
Written education should contain at minimum, goals of treatment, duration, schedule,
names of drugs and supportive medication, potential interactions, symptoms requiring
intervention of healthcare provider, self-administered treatments, handling of body secretions,
follow-up appointment information, and finally pertinent contact information (Neuss et al., 2017,
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p. 34). There is no definitive recommendation as to which type of educational materials are more
beneficial than another. In one randomized controlled study, a simple educational handbook led
to decreased adverse effects (Yuce & Yurtsever, 2017). The evidence does strongly support that
written content in conjunction with the verbally presented material is superior (Apor et al., 2018;
Garcia, 2014; Mollaoglu & Erdogan, 2014; Sahin & Erguney, 2015; Sahin et al., 2016). In both
Keener and Winokur, (2018) and Milanti et al., (2016) additional media are used. Benefits were
revealed that use of a digitally recorded presentation and a video decreased anxiety and improved
recall of knowledge (Fee-Schroeder et al., 2013; Keener & Winokur, 2018). The
recommendation of using audiovisual material was also noted by Papadopoulou et al. (2017). A
secondary benefit of the standardization process was found by Gallegos et al. (2019) in which
nurses reported significant improvement in satisfaction.
Evidence-Based Practice: Verification of Chosen Option
Based on the literature review, this Quality Improvement (QI) project aimed to provide
education to all chemotherapy-naïve patients using audio, visual, and written material. The
program included using an electronic medical record (EMR) to order an educational session, an
in-person 30–60-minute nurse-led educational group class using verbal and multimedia
resources, and a handbook/binder of written material (see Appendix C), all provided while
allowing time for patients and their family to address questions or concerns.
The patients were asked to use the National Comprehensive Cancer Network (NCCN)
Distress Thermometer (NCCN, 2018) to evaluate distress levels prior to their first chemo and
again prior to their Cycle 2 (see Appendix D). The educational material provided was easy-toread in plain language that is appropriate for all health literacy levels (Centers for Medicare &
Medicaid Services [CMS], 2018). The goal of this project was to provide quality education to all
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prechemotherapy patients to improve quality of life by providing knowledge and decreasing
distress.
Theoretical Framework/Evidence-Based Practice Model
The theoretical framework of Mishel’s Uncertainty in Illness was used to guide the
project. Mishel’s theory explores the concept of uncertainty when being diagnosed with a new
illness (Mishel, 1990). Especially in the case of chronic illness such as cancer it is common for
patients to feel stressed and have difficulty coping. According to Zhang (2017), patients who are
undergoing cancer treatment have higher reports of uncertainty than those undergoing
surveillance. Some of the causes for the uncertainty stem from lack of information about their
disease, not understanding treatment courses, and poor coping with day-to-day tasks (Zhang,
2017).
Mishel’s Uncertainty in Illness theory is comprised of four main parts: antecedents
generating uncertainty, appraisal of uncertainty, coping with uncertainty, and adaptation to
illness (See Appendix E). In the first component, new stimuli such as a cancer diagnosis is
processed by patients according to cognitive coping abilities and support systems. In the second
component, patients appraise the uncertainty, in this case a cancer diagnosis, which can be
perceived as a threat or an opportunity that can have a positive outcome. In the coping phase,
patients use strategies depending on their perception of the diagnosis. These strategies can range
from seeking information and education, family and emotional support, or other methods of
coping such as avoidance. In the final phase of Mishel’s theory the patient adapts and adjusts to
the new illness (Zhang, 2017).
According to Mishel (1990), uncertainty is highest early in the illness trajectory. This is
the time when a diagnosis is made, and a patient learns their life has been changed dramatically.
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How the patient copes with their diagnosis and the types of support available will be the
foundation of how they perceive a new way of life. Support from healthcare providers can be
beneficial toward promoting integration of the new illness and way of life as one that can be
adapted to and the instability and uncertainty perceived as natural (Mishel, 1990). Arming the
patient with information and tools, as done in this QI project, at the time of highest uncertainty is
likely to be beneficial toward promoting patient autonomy and acceptance. Discussions about
treatment goals, education in several formats that are literacy-appropriate for patients and their
family as part of this project aimed to decrease anxiety and distress, thereby improving the
patient’s quality of life.
Methods
Project Design
The QI project utilized the Plan-Do-Study-Act (PDSA) model. In this model, a test for
change is made (plan), the test is carried out (do), the results are analyzed (study), and
improvements and modifications (act) are suggested (Institute for Healthcare Improvement,
2019). A QI team was created that consisted of a physician, charge nurse, chemo nurses, and the
assistant office manager. The team’s aim was to facilitate the work planned by the DNP student
to decrease distress and improve the quality of life for patients prior to starting chemotherapy.
The DNP student compared quantitative and qualitative data from the pre- and post-intervention
DT scores. A patient satisfaction survey was provided at the completion of the project, which
allowed for patient input and suggestions for improvements. This non-validated survey created
for the project was scored and analyzed by the DNP student. The survey was intended to be brief
to prevent overwhelming patients with paperwork but still be useful for gathering insight toward
patient perceptions of the educational experience.
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Ethical Considerations/Protection of Human Subjects
The University of Massachusetts, Amherst (UMass) IRB approval was obtained prior to
initiating the DNP Project. All patients included in the QI project were protected by the Health
Insurance Portability and Accountability Act of 1996 (HIPAA) in order to protect privacy and
maintain security of health information (U.S. Department of Health & Human Services, 2017).
All information collected as part of the project contains no patient identifiers. Confidential
information was coded using identification numbers. This information has been stored on an
encrypted, password-protected storage device that was only accessible by the DNP student and
the charge nurse. IRB approval appears as Appendix F.
Goals, Objectives, and Expected Outcomes
The goals for this QI project were aimed to reduce distress by providing education to all
patients who were scheduled to start chemotherapy as part of their treatment plan. The specific
intent of the project was to (a) improve the education of all chemotherapy-naïve patients before
they began treatment, (b) provide education using a brief voice-over PowerPoint presentation, (c)
provide an in-person nurse-led verbal education session lasting 60 minutes, and (d) provide
detailed written material for each patient. Distress was measured using the NCCN Distress
Thermometer (DT) and Problem List (PL). The scores were totaled and compared pre- and posteducational intervention. Patient satisfaction (Appendix G) was also measured using a brief
Likert scale questionnaire. See Table 1 below.
Table 1
Goals, Objectives, Expected Outcomes, and Results of Quality Improvement Project
Goals
Improve education of
chemotherapy-naïve

Objectives
All patients will
receive an order for
education prior to

Expected Outcomes
All patients meeting inclusion
criteria will have education.

Result*
Objective
Met

NURSE-DELIVERED STANDARDIZED CHEMOTHERAPY
patients pretreatment.
Voice-over
PowerPoint
presentation.

initiation of first
chemotherapy.
Develop brief 8–10100% of patients will be provided
minute voice-over
PowerPoint presentation during
PowerPoint
teaching session.
presentation that
includes basic
overview of
chemo/infusion
center by 9/2019.
Provide an in-person Provide patients with 100% of patients will receive
nurse-led verbal
verbal education and verbal education session.
education session
allow question and
lasting 60 minutes.
answer time,
encourage
family/caregiver
attendance.
Provide detailed
Develop written
100% of patients will receive a
written material for
binder/folder using
customized binder/folder prior to
each patient.
evidence-based,
starting treatment.
literacy-appropriate
materials that is
customizable by
9/2019.
*See results sections, page 22 **See results, page 22
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Objective
Not
Met **

Objective
Met

Objective
Met

Project Site and Population
The site for this QI project took place at a private physician-owned hematology and
oncology practice in the state of Florida. The practice location is one of over 100 in the
organization. It contains 30 chemotherapy chairs, has seven practicing physicians, and eight
nurse practitioners. It serves adult patients with all types of cancer. Approximately 10–15
patients per week start chemotherapy in this practice location, and it was estimated that only 50%
were receiving formal chemotherapy education by nursing staff. The location of the practice was
in the town of The Villages, Florida which is a unique, large, and fast-growing age-restricted
community. As of March 2019, it had a population of approximately 120,000 residents

NURSE-DELIVERED STANDARDIZED CHEMOTHERAPY

17

(Straehley, 2019). The median age is 70 years old with 97% English-speaking and 2% Spanishspeaking residents (Town Charts, 2017).
Barriers and Facilitators
The success of the QI project relied heavily on project stakeholder buy-in. All the
physicians and nurse practitioners in the practice had to be engaged so that 100% of the eligible
patients were approached to participate. Providers in this location rotate daily; the DNP student
provided a detailed overview of the project in writing and on a one-to-one basis with each
practitioner whenever possible. Internal emails regarding planning and implementation of the
project were sent to all project team members. The charge nurse was initially met with to discuss
the project information and plans. Brief weekly meetings were held with the charge nurse to
discuss patient scheduling and feedback about the project’s implementation and content.
Involvement of the patients and their significant others was considered the foundation of
the project. Reduction of anxiety and providing patient-centered care is imperative to quality
care. Encouragement of family and caregiver support when available is important not only for
the patients but to allow for questions to be answered. One of the greatest facilitators of the
project was the desire of all the practice staff to provide quality care that is safe and causes the
least distress to cancer patients. Barriers to the project included lack of buy-in by staff and
physicians, which mostly occurred due to time constraints, scheduling, and workload. Patients
can often start treatment just days after being diagnosed. This leads to urgency in starting
treatment. In those rare cases, patients were scheduled outside of the regular education session
and were provided education on a one-to-one basis.
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Cost-Benefit Budget Analysis
The costs for this QI project were minimal. The previous method for providing patient
education was to print material in the office and place it in a folder. It is difficult to estimate
what the previous costs were as materials were part of the office supplies. Costs incurred for this
project included printing the educational handbook created by the DNP student. No additional
staff salary costs for this project were required as the charge nurse was met with during normal
working hours. The verified neutrality of costs highlights the ability for this project to be
considered a sustainable intervention. A total breakdown of costs can be found in Appendix H.
Implementation: Overview
A homogenous sample was maintained for the project by excluding patients scheduled to
receive other agents such as immune therapy or oral agents. The term chemotherapy for use in
this QI project included all intravenously delivered anti-neoplastic chemotherapy agents. The
patients were divided into two groups. Implementation of the project began with patients in
Group 1 who were given no intervention. This group received the standard of practice for
education which varied from education provided by their physician, education provided by
nursing staff just prior to chemo, or a group led education provided by the charge nurse. Patients
in Group 2, the enhanced education group, were scheduled for Patient Education as part of
discussions with their physician about treatment plans. When chemotherapy orders were placed
in the EMR, the option to choose Patient Education was made. At the end of each appointment,
patients were taken to the checkout desk, where tests, follow-ups, and chemotherapy infusions
were scheduled as part of usual procedures. The checkout staff were notified of the DNP
student’s QI project to ensure that all patients scheduled for their first chemotherapy had ordered
Patient Education and the time was scheduled appropriately.
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The charge nurse populated a list of patients at the end of each week to prepare for
chemotherapy medication ordering. This list also identified which patients were eligible to
participate in the DNP project. A conference room large enough to hold patients and their
significant others was reserved for the once weekly verbal educational session led by the charge
nurse and DNP student. This was done on Friday afternoons in order to provide the enhanced
education to any patient scheduled to start chemotherapy the following week. Upon completion
of the 60-minute session, which began with a PowerPoint presentation, the patients were given
written handout material. Time was allowed by the DNP student and charge nurse for review of
the material and for any additional questions. The verbal session/PowerPoint included general
information about the infusions center, pharmacologic information, and common issues
experienced by patients receiving chemotherapy.
Based on observations made by the DNP student and the charge nurse, it was decided to
stop using the PowerPoint presentation after the first two enhanced education sessions. Patients
were noted to be focused on the slides and where to find the information on the slides in their
handouts. Once the PowerPoint was eliminated, patients were given a personalized education
handbook that was verbally reviewed page by page.
Measurement Instruments
In order to measure the outcomes of this DNP Project the following instruments were
used: NCCN Distress Thermometer and Problem List (NCCN, 2018) as well as a Patient Survey
developed by the DNP student. The DT instrument consists of a simple scale 0 (no distress)–10
(extreme distress). The PL portion of the Distress Thermometer has yes and no questions related
to five different categories of common emotional and physical issues. This tool is useful for
screening distress and has been validated for different types of cancer, in various settings, and in
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multiple countries (NCCN, 2018). A meta-analysis (Ma et al., 2014) of 42 studies found, when a
cutoff score of 4 is used, a pooled sensitivity of DT to be at 81% (95% CI, 0.79–0.82) and the
pooled specificity to be 72% (95% CI, 0.71–0.72). The PL section of the tool was created by the
NCCN Distress Management Panel and has been validated by two studies (Graves et al., 2006;
Tuinman, Gazendam-Donofrio, & Hoekstra-Weebers, 2008). The PL is beneficial as a general
baseline needs assessment. The patient survey tool is brief, consisting of four Likert-scaled
questions (5 highest, 1 lowest), two yes or no questions, and a place to provide written
comments.
Data Collection Procedures
Data collection began with the first group of patients by reviewing the EMR for patients
who were planned to start Cycle 1 on Day 1 of their chemotherapy. This was done with
assistance of the charge nurse. Patients were approached during the start of their chemotherapy
while in the infusion room. The DNP project was discussed with each patient, a consent form
was completed, and a signed copy returned to the patient. Each patient was provided the NCCN
DT and PL. A spreadsheet was created to record patient medical record numbers, the date of
Cycle 1 Day 1 and the date they would start Cycle 2 Day 1. The first group of patients were
chosen to participate without any intervention in the usual educational processes or changes in
current procedure; it was recorded if they received any formal chemotherapy education or not.
Each patient included in the project on Cycle 2 Day 1 was approached while in the chemo room.
They were asked to complete the DT and PL a second time and were given the patient survey
form to complete. Scores from the patient survey were recorded as well as any written comments
made by patients. All data was recorded into an Excel spreadsheet, including patient
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demographics. All de-identified data was kept in the locked file accessible only to the DNP
student and the charge nurse.
Data collection for Group 2 patients was done in similar format. Patients planned to start
chemotherapy were located by searching the EMR and discussions with the charge nurse. The
patients were each scheduled for the enhanced chemotherapy education class through the Patient
Education order in the EMR. The patients were approached about the DNP project at the
beginning of the class. They were each provided the DT and PL, along with the consent form and
the patient education handbook created by the DNP student. It was later determined, based on
observations, to not distribute the DT and PL at the education class because patients were
overwhelmed with paperwork during the class. Instead of at the class, patients were given the
paperwork on Cycle 1 Day 1 of their chemo while in the infusion room. Data was collected and
privacy maintained as done with Group 1 patients. Handwritten comments on patient surveys
were also recorded and arranged in a table.
Data Analysis
The de-identified data of Group 1 and Group 2 patients included both pre-and post-DT
and PL, the patient survey, handwritten comments, and demographic data. This information was
used to create an Excel spreadsheet. The thermometer score from the DT was recorded as
numerical value 0–10. The 39 questions of the PL were recorded as “Y” or “N.” The results of
the Likert scale patient survey were recorded numerically 1–5. A final column was created to
record handwritten comments. The spreadsheet was used by the DNP student to analyze pre-and
post-scores of Group 1 and Group 2 patients.
At completion of data collection, the results were entered into the Statistical Package for
Social Sciences (SPSS) and coded appropriately for analysis. Descriptive statistics were used to
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report demographic characteristics (see Table 2), PL and patient satisfaction scores. Ratio-level
data from the pre- and post-DT were analyzed using paired sample t-tests for each group and
independent sample t-test for between-group comparisons. The frequency of individual items
reported on the PL can be seen in Table 3. Qualitative data was collected and recorded from
handwritten comments on the patient satisfaction survey (see Table 4). Additionally, patient
satisfaction scores were compared along with the number of calls to the nurse triage line/visits to
office, and number of visits to ER and presented in table format.
Results
Demographics
Non-Intervention Group
Group 1 of the QI project originally contained 21 patients, yet unfortunately one patient
died prior to post-testing, leaving (n = 20). A second patient declined participating in the postdata collection and was therefore excluded from analysis, with remaining total participants (n =
19). The average age of Group 1 participants was 73.21 years with the minimum age of 43 and
maximum age of 85. Fifty-eight percent of participants were male (n = 11), while females in
Group 1 accounted for 42% (n = 8). A variety of cancer types were found among the
participants, with the most common cancer diagnosis being lung cancer 15.8% (n = 3). Advanced
stage cancer was found to be the most common; stage IV cancer, which included stage IVA, and
IVB, was the most common at 63.2% (n = 12). A total of (n = 8) patients in this baseline group
attended a group setting educational class given by the charge nurse with the usual standard
procedure for education, and a total (n = 11) had some other type of education such as one-onone with the RN in the infusion room just prior to administration of chemo.
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Intervention Group
Nineteen patients agreed to participate in Group 2 of the DNP project and receive the enhanced
educational session that was created for the DNP project. The average age in this group was 71
years old with a minimum age of 52 and maximum of 87 years. Most participants in Group 2
were female 52.6% (n = 10). The most common type of cancer in Group 2 was breast 26.3% (n =
5). Twenty-six percent (n = 5) had advanced Stage IV cancers.
Table 2
Participant Demographics
Group 1
N = 19
Patient Characteristics
Age (years)
40–50
51–60
61–70
71–80
81–90
Gender
Male
Female
Cancer Type
Breast
Colon
Diffuse Large B-Cell
Lymphoma
Head & Neck
Lung
Lymphoma – other
MDS
Melanoma
Multiple Myeloma
Neuroendocrine
Gyn (Ovarian/Cervical)
Pancreatic
Prostate
Rectal
Other

Group 2
N = 19

n

%*

n

%*

1
2
1
10
6

5
10
5
50
30

2
6
8
3

10
32
42
16

11
8

60
40

9
10

47
53

1
1
2
2
3
1
1
1
1
1
1
1
1
1
1

5
5
10
10
15
5
5
5
5
5
5
5
5
5
5

5
1
1
1
4
1
1

26
5
5
5
21
5
5

1

5

1
1

5
5

2

11
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Cancer Stage
Missing
Extensive
High Risk
I
II
III
IV
Low Risk

3
1
1
1

15
5
5
5

3
10
1

15
50
5

24

2

11

3
5
3
5

16
26
16
26

*Rounded to nearest whole number.
Distress Thermometer
Group 1 vs. Group 2 Post-Distress Thermometer Comparisons
Group 1 (no-education intervention group) was compared to Group 2 (who received the
enhanced DNP project educational intervention). Post-DT scores were compared between the
two groups. The DT instrument is measured as 0 (no distress)–10 (extreme distress). The lower
the number a patient chose indicates they felt less distress. A higher number indicates more
perceived distress. Results were Group 1 (M = 3.00, SD = 2.65), and Group 2 (M = 2.21, SD =
2.72). An independent samples t-test indicated there was no statistically significant difference in
the post-DT scores of Group 1 when compared with Group 2, t(36) = .907, p = .814.
Group 1 Pre- and Post-Distress Thermometer Score Comparisons
The scores of Group 1 participants were compared pre- and post-start of chemotherapy
using paired samples t-test. The results showed that patients had higher scores before the
educational session (M = 4.95, SD = 2.80) than they did after receiving the educational session
(M = 3.00, SD = 2.65). The difference found was 1.95 points between the pre-DT scores and the
post-DT scores. A paired samples t-test found this difference to be significant, t(18) = 2.787, p =
0.012.
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Group 2 Pre- and Post-Distress Thermometer Score Comparisons
A comparison was made within Group 2, those who received the DNP project enhanced
educational intervention. The DT scores were compared pre- and post-chemotherapy. The preDT scores were compared with the post-DT scores. The results showed that patients had higher
distress scores before the educational session (M = 4.95, SD = 3.36) than they did after receiving
the educational session (M = 2.21, SD = 2.72). The difference found was 2.74 points between the
pre-DT scores and the post-DT scores. A paired samples t-test found this difference to be
significant, t(18) = 3.311, p = 0.004 (see Figure 1).
Figure 1
Distress Thermometer Scores for Both Groups.

Problem List
The PL contains 39 yes/no questions. Each group was provided the PL before Cycle 1 of
chemotherapy and a second time before Cycle 2. The “Emotional Problem” section of the
problem list contains seven items: depression, fears, nervousness, sadness, worry, loss of interest
in usual activities, and spiritual/religious concerns. When comparing frequency data, both groups
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reported yes more often in the pre-test than in the post-test to all questions except in one. Loss of
interest in usual activities had an additional yes answer in the Group 2 post-test.
The Physical Problems section contains 22 items. The most frequently reported symptom
in both Group 1 and Group 2 was fatigue. This number increased in Group 1 from 52.6% to
78.9% and in Group 2 it remained constant at 47.4%. Sleep was the 2nd most reported problem in
Group 1 and remained constant in both pre- and post-testing. The second most common problem
in Group 2 was eating (26.3%) both pre- and post-testing and sleep, which increased in the posttest by 5.3%.
Table 3
Problem List Frequency
Group 1
Child Care
Housing
Insurance
Transportation
Work/school
Treatment decisions
Dealing with children
Dealing with partner
Ability to have children
Family health issues
Depression
Fears
Nervousness
Sadness
Worry
Loss of interest
Spiritual/religious
Appearance
Bathing/dressing
Breathing
Changes in urination
Constipation
Diarrhea
Eating

Pre0
0
3
1
0
5
1
1
0
2
2
7
9
4
10
3
0
2
1
2
4
7
0
1

Group 2
Post1
0
1
1
2
1
1
0
0
2
2
4
5
4
6
5
0
2
1
4
1
5
3
4

Pre0
2
6
1
1
5
0
3
0
2
4
4
10
6
9
4
1
4
2
2
3
2
3
5

Post0
1
2
2
1
1
0
2
0
0
3
3
7
2
5
5
0
5
3
2
1
8
5
5
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Fatigue
Feeling swollen
Fevers
Getting around
Indigestion
Memory/concentration
Mouth sores
Nausea
Nose dry/congested
Pain
Sexual
Skin dry/itchy
Sleep
Substance use
Tingling hands/feet

10
4
1
1
4
2
1
2
2
6
2
5
7
0
2

15
4
0
4
5
6
2
6
3
4
3
6
7
0
5

27
9
2
2
4
3
3
2
1
2
4
0
2
5
0
2

9
1
3
4
4
4
5
6
3
1
0
6
6
0
4

Patient Satisfaction Survey
Comparison of Group 1 vs. Group 2 total patient satisfaction scores shows patients in
Group 2 reported higher satisfaction 16.89 and 19.00 respectively. All patients in Group 2
reported the highest score possible of 5 points. There were seven calls to nurse triage line or
visits to office in Group 1 compared with four for Group 2. Patients in Group 1 went to the ED
or urgent care more (n = 2) than in Group 2 (n = 1).
Table 4
Satisfaction scores and emergency calls/visits
Satisfaction Score
Called Nurse Triage Line
Went to ED/Urgent Care

Group 1
M = 16.89, SD = 4.665
n=7
n=2

Group 2
M = 19.00, SD = 1.826
n=4
n=1

Patient Survey Comments
Each individual comment written on the patient survey instrument is presented verbatim,
and in their entirety, below in Table 5.
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Table 5
Patient survey comments
Patient Satisfaction Comments
Group 1
Nurses are very helpful.
Issues with constipation.
Too educational.
Everything well organized. Nurses very
attentive.
Immune therapy should be separate from
chemo.
Nurses very helpful.
Patient declined “Very upset I did not go to a
class”

Patient Satisfaction Comments
Group 2
The class was excellent and extremely
informative.
All concerns were answered.
Handouts were great
Pleasure to go.
Learned so much with the questions and
answers.
Class extremely helpful.
Everything has been good.
I feel very informed.

Interpretation/Discussion
The enhanced education program was created based on observations made for a need to
improve standard operating procedures in a large oncology practice in order to reduce anxiety
and distress to cancer patients. There was one patient in Group 1 who completed the preinformation but was upset she did not receive group education and declined to complete any
further information. The patients who participated in the group program were receptive to
receiving education and scheduling the session prior to starting chemo. Many patients brought
families and caregivers, which was reported to be helpful. It was noted during the question-andanswer portion of the session that, when a patient asked a question, it was often followed by
other patients and family members asking questions. The group setting made for a comfortable
environment where patients could feel safe and not rushed.
It is important to discuss that all patients received some type of pre-chemotherapy
education as it would be unethical to have a no-education group vs. an education group. Another
important observation made regarding higher scores in the pre- and post-scores of both groups is
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that patients are likely less distressed when starting Cycle 2 of chemotherapy because they had
some familiarity with the process and known expectations. Many may have also had a follow-up
appointment with their physician or nurse practitioner and had an opportunity to discuss
concerns.
Results of the patient satisfactory survey indicated higher satisfaction among those in the
enhanced education group. Questions 5 and 6 of the survey “Did you call the triage nurse or
come to the office with a concern about your treatment” and “Did you visit the Emergency
Department, Urgent Care or Hospital for an emergent issue regarding your treatment” indicate
that patients who received the enhanced educational session called or came to the office less than
the group that did not receive this session (36.84% vs. 21.05%). Seven patients in Group 1 either
called the nurse triage or visited the office due to adverse effects; of those, six did not attend any
group educational session The two patients who did visit the Emergency Room, Urgent Care, or
Hospital had not attended any group education. This may indicate that while patients still have
similar side effects from chemotherapy, as noted in the PL, when they are provided with
education, they are better equipped to handle them at home requiring less intervention.
The cost for treatment of dehydration and/or nausea is approximately $330 per patient.
Fewer calls to nurse triage and visits to the infusion center for hydration, anti-emetics, and other
treatments reduces costs. This includes reduced chair time in the clinic, nursing services, and
supplies. Providing education can be billed under level 1 office visit, for which the fee is
approximately $53.00. The amount collected by insurance varies, e.g. Medicare is $21.20. This
fee is enough to pay for the cost of materials. Education did not eliminate all potential side
effects or need for patients to come to the clinic when appropriate; however, the number of
occurrences were reduced through improvement of patient self-efficacy.
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While some of the providers of the practice were not immediately receptive to the change
in usual practices, the majority did participate by sending their patients to the enhanced
education session. The charge nurse, who is responsible for patient education going forward, has
adopted this new enhanced educational technique and is using the handbook created for the
project. A second office location has also started using the handbook in their office. Ongoing
discussion among the physician partners is to now implement a standardized education session
for all chemotherapy patients on a regional level. While statistical significance was not met
between the means of Group 1 and Group 2 post-test scores in this project, the impact in
changing the customary procedure to a program that supports best practice as seen in the
literature will prove beneficial to patients.
Theoretical Outcomes
The theoretical approach to this DNP QI project, Mishel’s Uncertainty in Illness provided
a valuable framework. Throughout the implementation and analysis of the project, application of
the theory was found to be relevant. A patient’s perception of a chronic illness can be improved
using positive coping resources such as education. Reducing confusion and disorganization early
in the trajectory of cancer treatment can assist patients’ outlook on their condition (Zhang, 2017).
As found in the patient satisfaction survey and comments, those in the enhanced education group
reported a higher level of satisfaction. It’s possible that the tools used for measurement in this QI
project were not precise enough in the capturing of anxiety levels related to anticipation of
chemotherapy and how education directly reduced those levels. While uncertainty cannot be
eliminated, continued efforts to provide a base of knowledge early in the treatment trajectory can
allow for better coping and fluidity with change. A patient’s ability to adapt can be improved.
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Uncertainty and change can be viewed as something still within their control instead of leading
to feelings of danger and helplessness (Mishel, 1990).
Implications for Nursing
A theme noted among all the patients that participated in the project is the value of
nursing care and the consensus that they were listened to and felt comfortable asking questions.
When education was performed in the group enhanced education session verbal comments were
in praise of how much the class helped and that they really enjoyed attending. Though the
sample size was small in each group fewer calls to nurse triage and visits for urgent care show
that empowerment through education equips patients with tools needed for side effect
management. This project did not include a nurse satisfaction survey; however, nurses did
verbally recognize they appreciated that patients who attended a dedicated group education
session were more prepared to start chemo when they came to the infusion center for the first
time. Patient that have advanced preparation are better equipped to handle expectations on their
first day. Standardizing and improving patient education ads value by providing nursing staff
with preprinted, evidence-based resources. This eliminated time nurses would need to spend on
locating and printing materials and put less pressure on chemo nurses who carry heavy
workloads on a daily basis. The nurses reported that patients who were well prepared also had
less anxiety and nervousness. Patients had the chance to review educational material at home and
come to chemo with specific questions and concerns instead of starting the education process
from the beginning.
Conclusion
Anxiety is a common reaction when a patient learns they have cancer and will be starting
chemotherapy. Providing patients with a structured educational toolkit that provides both a
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verbal session where questions can be addressed as well as written material that can be
referenced at home can help to reduce the level of anxiety. The PowerPoint presentation was
found to be distracting during the enhanced educational session; however, it may be beneficial if
made available upon request electronically or linked on the practice website, thus allowing
patients and caregivers to view it at home as an additional resource. Providing patients with
appropriate resources about their self-care and potential adverse effects of treatment can
potentially lower the severity of adverse effects, allow patients to treat common symptoms at
home, and reduce the number of emergency visits to the clinic they will need to make.
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Appendix B
Literature Review Reference Matrix
Author/
Design

Hypothesis

n = Setting

Methods/ Measures

Data Analysis

Outcomes/Results

Survey developed to assess
effect of specific
chemotherapy educational
curriculum

Analyses performed
with SAS software

Structured nurse-led
chemotherapy educational
session 60–90 minutes,
family/support encouraged
to attend

Ordinal value for
multinomial
distribution
generalized linear
model to model
random effects
analyzing results
across time

Significant
increases observed
in perceived
knowledge of
treatment schedule,
potential side
effects, and use of
meds to prevent
nausea

Strengths
Weaknesses

Grade/Level of
Evidence
1. Apor et al.
(2018)
Nonexperimental
Level III
Quality B

In preparation of
chemo, understanding potential side
effects, goals,
treatment schedule,
contact info will
reduce stress and
anxiety, leading to
better compliance,
quality of life,
better outcomes

n = 196

+ handout given
1st Survey presented
before teaching
appointment;
2nd survey before Cycle 1 3rd survey before Cycle 2

Reduced
generalized anxiety
about treatment (p =
0.0294).
Completely
understand how to
take nausea
medicine, n = 26
survey 1 vs. n = 130
survey 3 (p <
0.0001)
Conclusion: nurse
led chemo after
initial physician
discussion but prior
to starting chemo
improves patients

S:
Data analyzed after
one educational
session
Discussed that n =
52 patients had no
perceived
knowledge after
meeting with dr
only and n = 52 had
minimal
information about
treatment side
effects

W:
Developed own tool
by the Brown
University
Oncology Research
Group (BrUOG) =
developed by
investigators &
reviewed by focus
group of practicing
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2. FeeSchroeder et
al. (2013)
Quasiexperimental
Level III
Quality C

Instructing patients
on side effect
manage-ment and
behavioral
strategies can
decrease healthrelated distress,
increase coping,
reduce anxiety, and
promote self-care

n = 81
66 patients
and 15 care
givers

40

Evidence-based
chemotherapy curriculum
focused on: self-care
strategies for side effects

SPSS was used to
summarize data

11 min DVD was created
utilized experts from Mayo
Clinic were involved &
utilized with a nurse led
group discussion

(mean, SD)

Descriptive statistics

perceived
knowledge of
treatment schedules,
anticipated adverse
effects, and how to
manage
complications

oncologists &
reviewed by IRB

65 patients (98%)
had increased selfreported
understanding of
side effects

S:

98% had increased
motivation to use
self-care strategies
100% confidence to
manage side effects

n = 31 47% found
benefit in the class
even though they
had started chemo
DVD was
inexpensive to
create
W:

Post class study
immediately following

No statistics
provided

And n = 42 completed an 8
week follow up survey

31 patients had
already begun
chemo prior to
attending class
No convenience
sample
Class was open to
anyone who chose,
size varied from
session to session
Survey not
validated
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3. Gallegos et
al. (2019)

Quasiexperimental

Standard-ization of
chemo-theapy
education
improved nurse
and patient
satisfaction

n = 80
patients preintervention

Questionnaires given to
patient cycle 1 day 1 of
new treatment

n = 84 post
intervention

Nursing education staff
given pre- and postintervention questionnaires

Level III

n = 30
nurses pre

Quality C

n = 25 post

4. Garcia
(2014)
Integrative
Review
Level IV
Quality C

Question: what is
the most effective
interven-tions for
anxiety in patients
beginning chemotherapy?

n = 10
articles

41
SAS used for
descriptive statistics
p < 0.05
t-test and ANOVA

education: prechemotherapy checklist for
team, group led education
class, written material,
short video, template in
EMR to document

Literature search of
CINAHL, MEDLINE,
ProQuest, Joanna Briggs
Institute Clinical Online
Network for Evidence of
Care and Therapeutics,
Cochrane Collaboration
and Library and National
Guidelines Clearinghouse

nursing staff
increased
satisfaction, overall
26.5% (p <
0.001)

patient satisfaction
scores unchanged,
high pre- and post

n/a

S: standardized
education improved
nursing satisfaction
related to education
W:
small study size,
patient satisfaction
scores markedly
high pre- and post

women had high
post satisfaction
scores regarding
resources for side
effect management
(4.4 vs. 4.1; p =
0.02)

tool used not
specific to side
effect questions

9 studies = patient
education is
effective in
decreasing anxiety

S:

Specifically –
information about
treatment, side
effect management,
orientation to
infusion room
setting

Evidence appraisal
methods explained

Best done prior to
initiating chemo
Written and verbal
instruction allows

This institution also
already has a nurse
navigator to provide
information

Methods clearly
described

Implications for
nursing: RNs are
appropriate
healthcare providers
to lead educational
sessions
W:
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5. Keener
(2018)
Quasiexperimental
Level III
Quality C

What effect does
digitally recorded
stand-ardized, prechemotherapy
teaching methods
have on knowledge
recall in patients
receiving first
chemo?
What effect on
post-treatment
anxiety?

n = 92
control
n=5
tradition.
digital
English n =
75
digital
Spanish n =
12

Pretest/posttest design
Intervention group
received digitally recorded
education of 9-minute
recorded presentation

42
pts to continue
learning after initial

studies are older
than 5 years, though
still relevant

SPSS used
inferential and
descriptive statistics

Anxiety scores
lower education for
all groups

S:

paired-sample t tests

Significant decrease
in tense/being
worried

(Common side effects,
treatment plans, tips for
home care, lifestyle
changes, chemo admin,
what to expect during
infusion, team overview,
discharge instructions)

(p < 0.001)
All groups
knowledge recall
improved

ASCO
guidelines
Agree II score
67

Adults and
pediatric
cancer
patients

Updated in 2011 and
revised 2013
Joint workshop with
stakeholders on 5/12/2015
Extensive literature search
included 97 articles for this
update

Low cost and
effective method

Survey not tested
for reliability or
validity

Both groups
question/answer time and
written material
Purpose to update
ASCO/ONS
chemo-therapy
Admin-istration
Safety Standards

Digitally recorded
video can be
beneficial for
patients and time
efficient for nursing

W:

Standard group =
traditional lecture-based
education

6. Neuss et al.
(2017)

Two types of
education analyzed

Small sample size
Tool used very brief
n/a

Education prior to
first chemo should
include the
minimum

S:

Contain both verbal
& written
information

Recently updated

Diagnosis

Industry guideline
recommend-ations
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Expert panel

Goals of tx,
duration, schedule,
supportive
medications,
adverse effects,
symptoms, follow
up plans

Public content

Should include
family
7. Milanti
(2016)
Quasiexperimental
Level III
Quality B

Psyco-educational
therapy integrates
psyco-therapeutic
and educational
interventions can
address
psychological
distress of breast
cancer and cervical
cancer patients

n = 100

Pretest/posttest design

50 intervention group

Comparison group not
treated with intervention
but standard care

50 control
group

SPSS was used for
data analysis
Mann-Whitney U
test

42-minute psychoeducational video while
receiving chemo (3 parts:
positive reappraisal,
education, and relaxation)

Distress mean
before the
intervention 3.9
(95% CI: 3.41-4.43)
and median 4.0 SD
2.58
In the intervention
group the distress
level decreased
(p=0.0001)
64% had less
clinically significant
distress after the
intervention

The education portion of
the video included info on
chemo, symptom
management, physical and
psychological symptoms
(info summarized from
ASCO, NCCN, and ONS)

Planned education
can decrease side
effects of chemo
and improve QOL

n = 120

C-SAS

60 control

Control group received 3
education sessions:

One intervention
was used
W:
Do not know what
kind of education
the control group
had? what is usual
care
Non-probability
sampling methods
Small size
Short period of time
between
intervention and
post intervention
data collection

Distress thermometer was
used

8. Mollaoglu
(2014)

S:

Median MannWhitney U test and
Wilcoxon signed
rank test

Statistically
significant (p <
0.05) decrease in
frequency of:

S:
Utilized both verbal
in person session
that include patient
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Quasiexperimental

60 exp.

Level II
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Education = verbal session
and 18-page booklet given
with session #1

SPSS used to assess
data

#1 before 1st chemo (40-45
min session)

Quality B

#2 prior to 2nd chemo (3040 min session)
rd

#3 before 3 chemo (no
time given)
C-SAS repeated after 3
chemo

rd

Nausea, vomiting,
constipation, pain,
infection signs,
problems of mouth
and throat, problems
of skin and nails,
appetite changes,
weight loss/gain,
feeling
distressed/anxious,
feeling pessimistic
and unhappy,
unusual fatigue, &
difficulty sleeping

& family with a
handwritten booklet

W:
Not-randomized
3 teaching sessions
time consuming
Intervention not
checked after first
chemo

statistically
significant
decreases in
severity of eleven
symptoms and
discomfort level of
nine symptoms
9.
Papadopoulou
et al.(2017)
Longitudinal
study
Level III
Quality B

How is selfefficacy characterized through out
chemo?

Patients to
receive
chemotherapy

Anxiety was measured
prior to first chemo and at
the start of each subsequent
6 cycles

Is self-efficacy a
predictor of lower
anxiety?

n = 135

STAI- State Trait Anxiety
Inventory and

Is self-efficacy a
predictor of
improved QOL
during chemo?

SUPPH Strategies Used by
People to Promote Health

Descriptive statistics
SPSS used
Longitud-inal
relationship
between HRQOL
and self-efficacy
scores
Bonferroni adjusted
sig level alpha
0.05/20 = 0.003

Significant
relationship
between selfefficacy (p < 0.05)
and state anxiety at
all time points
Significant (p <
0.05) relationship
between selfefficacy and
HRQOL scores.
Higher self-efficacy
associated with
increases in
functioning
(physical, emotions,

S:
Findings support
empowering of
patients to less
stress during chemo
– enhanced by
education
Specifically
mentions use of
audio-visual
education
W:
Not specifically
looking at education
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and functional) and
lead to fewer cancer
related issues during
chemo (p = 0.0001).

10. Sahin
(2015)
Quasiexperimental
Level II
Quality B

Nurse education
planned model will
improve quality of
life and adherence
to treatment

n = 140

Measure education

70 trial

Secondary aim=describe
symptoms

70 control

Chemotherapy symptom
assessment scale (CSAS)
About to receive chemo 1st
time:
<Prior to education
educational needs were
personalized>
1st session: verbal
information given to
patient + family 60-65 min
Booklet provided after the
session
2nd session prior to 2nd
chemo 30-45 min
3rd session prior to 3rd
chemo

CSAS completed 10 days
after the 3rd chemo

SPSS software used
for data analysis
Mann-Whitney U,
paired samples t, chisquare, Cronbach’s
alpha test

Statistically
significant changes
(p < 0.05)
Nausea and
vomiting,
distressed/anxious,
feeling
pessimistic/unhappy
, feeling unusually
tired and difficulty
sleeping less
common in
experimental group
Severity of
symptoms
Nausea/vomiting,
distress/anxious,
feeling
pessimistic/unhappy
, feeling, unusually
tired, and difficulty
sleeping less
common
Degree of
discomfort
nausea/vomiting,
distressed/anxious,
feeling pessimistic
unhappy, feeling

S:
Used verbal
teaching and a
booklet

W:
3 education session
time consuming
Intervention not
checked after first
session before 2nd
chemo
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usually tired, and
difficulty sleeping
were lower

11. Sahin
(2016)
Quasiexperimental
Level II
Quality B

Patients can
manage treatment
related symptoms
through
educational
interventions to
improve outcomes
such as QOL and
health status

n = 120
60 exp.

Educational intervention
conducted prior to first
cycle

60 control

Pre-test & post test

All with
stages I-III
breast
cancer

Verbal education session
50-55 minutes
Booklet provided at the
end of session
2nd session prior to 2nd
cycle 35-45 minutes
3rd session prior to 3rd cycle
– patients and family
CSAS completed 10 days
after 3rd chemo and QOL
index

SPSS used to
analyze data

Statistically
significant (p < 0.05)

X2 test or Fisher
exact test
Mann-Whitney U
test
Paired t test

CSAS and Quality of
Life Index-Cancer
Version

Symptoms
distress/anxiety,
feeling
pessimistic/unhappy
, feeling unusual
tired, and difficulty
sleeping less
common in posttest
experimental group
(p < 0.05)
Degree of
discomfort
distress/anxiety,
feeling
pessimistic/unhappy
, and difficulty
sleeping lower in
posttest exp group

S:
Booklet details:
pharm/non-pharm
info on chemo,
common adverse
effects
Only used 1
interventional
session
W:
Sample only breast
cancer patients

(p < 0.05)
Conclusion patients
in the intervention
group had higher
overall QOL

12. Yuce
(2017)
Randomized
controlled
study
Level I
Quality B

Does education
have an effect on
prevention of oral
mucositis and
improve QOL?

n = 60

Instruments used;

30 educ.
group

Scale for Assessing
Quality of Life in Cancer
Patients

30 control
group

and

Chi-square analysis,
Mann-Whitney U
Test, number,
percentage, mean,
standard deviation,
median

Oral Assessment Guide

p < 0.05

Statistically
significant
difference between
education group and
control group on
degree of mucositis
(days 5, 10, 15 &
21)

S:
Oral mucositis
common among
some chemo. (37%)
Randomized
controlled trial
W:

NURSE-DELIVERED STANDARDIZED CHEMOTHERAPY
Patient education booklet
created by researchers
(nutritional
recommendations,
recommendations for
dryness, recommendations
on issues of taste, smell
changes, use of oral
hygiene)
Routine nursing
recommendations in
another group
Oral Assessment Guide
days 5, 10, 15, 21

47
Statistically
significant
difference education
group and control
group experiencing
reduced saliva (5th
day)
Difficulty
swallowing (5th day)
Deterioration of
taste (5th day)
Avg. functional
scores (QOL)
significant
difference (p =
0.017)

Small study size
Focused on
education and
outcomes of one
specific side effect
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Written Education Materials

Chemotherapy
Patient Resources
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Phone Numbers

Main Number

(352)555-1212

Includes after hours and weekends
Nurse Triage Line
Includes medication refills

(352)555-1213

Billing Questions

(352)555-1214

Appointment Questions

(352)555-1215

Pharmacy

(800)123-4567

Website
For support, clinical trial, care management info: Flcancer.com

After Hours Calls
After hours will reach answering service.
Your call will be returned by either the physician or nurse practitioner or PA
on call.
Provide the following:
1. your diagnosis
2. chemotherapy you are receiving
3. date of your last chemo

(2)
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Preparing for Chemotherapy
Frequently asked questions

Q: When should I arrive for my appointment?
A: Please arrive at your scheduled time. Arriving earlier does not mean
you will be seen earlier

Q: What should I bring to occupy my time?
A: You may bring: tablets, books, newspapers, magazines or any reading
material. Please use headphones or ear buds so as not to disturb other
patients. ALL CELLPHONES SHOULD HAVE RINGER SILENCED

Q: Can I bring food or drinks?
A: We provide light snacks (peanut butter crackers & cookies), juice,
water, and ginger ale. You may bring other drinks & snacks with you.

Q: Can I bring a blanket or pillow?
A: We will provide you warm blankets and have a pillow. If you prefer you
may bring your own from home. The treatment room is kept at 70° F.

Q: Should I take my regular medications before coming?
A: Unless otherwise advised by your oncologist you may take all your
home medications

(3)
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Q: What is an infusion reaction?
A: Symptoms of a reaction include: itching, rash, hives, chills, headache,
muscle pains, dizziness, sweating, nausea/vomiting, cough, shortness of
breath, chest tightness, increase or decrease blood pressure, increase
heart rate, feeling like throat is closing, numbness of extremity or tongue.
LET YOUR NURSE KNOW IMMEDIATELY.

Q: Can I bring friends or family with me?
A: Every patient can bring one family member/friend with them to the
treatment room. However, if space is limited and the chair is needed for a
patient, we will ask the family/friend to return to the waiting room until a
chair is available.

Q: What is the WIFI information?
A: Network: FCSguest
Password: fcsnet08

Other common questions to ask:
Will I lose my hair? ____________________________________________
Is there any medications I should
avoid?______________________________________________________
____________________________________________________________
____________________________________________________________
Can I swim in a pool?__________________________________________
Can I exercise?_______________________________________________
Do I need to wear a mask or gloves?______________________________

(4)
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When to contact the office & urgent calls:
•
•
•
•
•
•
•
•
•
•

•
•
•
•
•
•

Chest pain – Call 9-1-1
Fever – temperature more than 100.5
Excessive shaking or chills
Uncontrolled vomiting – more than 4 times in 24 hours
Bruising or bleeding
Dizziness or light-headed
Blood in urine or stools
Severe constipation (no bowel movement for 3 days) or diarrhea not
managed by over the counter anti-diarrheal medication
Urinary pain, frequent urination, inability to urinate
Extreme fatigue (example – unable to perform regular Activities of
Daily Living such as fixing a meal, getting dressed, using the
restroom)
New pain location
Headache not relieved by ibuprofen or acetaminophen
Mouth sores
Unable to eat or drink
A brand-new symptom
Rash
Internet Resources

American Society of Clinical Oncology (ASCO) patient resources –
www.Cancer.net
Chemotherapy and side effects, Cleveland Clinic – www.Chemocare.com
American Cancer Society – www.Cancer.org
National Comprehensive Cancer Network (NCCN) patient resources
www.NCCN.org

(5)
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Your Treatment Plan
Cancer type/location/histologic
type:________________________________________________________
___________________________________________________________
Treatment goal:_____________________________________________
Chemotherapy:_______________________________________________
____________________________________________________________
___________________________________________________________

Time expected per treatment:
1st treatment: __________________________________________
Consecutive treatments: _________________________________
Frequency: __________________________________________

Medications to take at home before treatment:
(Ex: if you treatment includes Alimta or Taxotere you should be prescribed
dexamethasone the day before and after chemo)
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________

Prescriptions given:
____________________________________________________________
____________________________________________________________
____________________________________________________________
___________________________________________________________
(6)
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Port Information
What is a port?
Device implanted under the skin by a surgeon or radiologist
Small disc shape – quarter sized
Can be used to draw blood
Can be used for chemotherapy and other medications

Care of port
Will be flushed each treatment
Flushed every 4-8 weeks when not in use

(7)
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Understanding Your Blood Count
3 Main types of blood cells:

Name

Normal Ranges

Red Blood Cells (RBC)

Hemoglobin (Hgb)

12-16

Hematocrit (HCT)

37-47%

White Blood Cells (WBC)

4.2-10

Absolute Neutrophil Count (ANC)

1.5-6.5

Platelets

140-440

Common terms:
Anemia – Low Red Blood Cells
Neutropenia - Low White Blood Cells
Thrombocytopenia – Low Platelets

(8)
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Side Effect Management of Symptoms
Fatigue:
•
•
•
•
•

Space out activities and use rest periods
Good nutrition
Stay hydrated – drink 8-10 glasses fluids daily (decaffeinated drinks)
Engage in light to moderate activity daily such as walking
Rest when needed

Hair Loss Due to Chemotherapy
• Will vary depending on type of chemotherapy
• Will start to fall out around 14 days after first chemotherapy
• May choose to cut hair short
• Eyelashes and eyebrows may fall out
• May cause scalp tenderness
• Plan to shop for a wig before you start treatment if possible
• May grow back different texture or color
Anemia – Low Red Blood Cells
• Symptoms may include: fatigue, shortness of breath, dizziness,
lightheadedness, fast heart beat
• Things you can do: Get up slowly, rest often when needed
• Good nutrition
•
Thrombocytopenia – Low Platelets
• Platelets help blood to clot
• When low at risk for bleeding
• Signs of low platelets: easy bruising, small pinpoint red spots on
skin, blood in urine, blood in stools (black stools), bleeding from gums
or nose
(9)
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• Things you can do to prevent injury: use a soft bristle toothbrush,
blow nose gently, use an electric razor, avoid contact sports, avoid
using enemas, rectal suppositories, keep stools soft
• If injury or bleeding apply pressure to area
Neutropenia – Low White Blood Cells
• White blood cells fight infection
• Signs of infection include: temperature greater than 100.5 F, chills,
sweats, cough, coughing up secretions, mouth sores or white patches
in mouth or tongue, burning/pain with urination, redness or pain and
swelling of skin, pus or drainage
• May require injections to stimulate growth of white blood cells or an
on-body injector may be placed on you after your chemo
How to Reduce Risk of Infection:
•
•
•
•
•
•
•

Avoid those with colds or illness
Consult with physician before getting any vaccinations or dental work
Avoid large crowds if possible
Wash hands frequently
Brush teeth and good oral care
Wash fresh fruits and vegetables
Wear gloves when cleaning animal cages, fish tanks, cat litter, yard
work

Mouth Sores
•
•
•
•

Use a soft bristled toothbrush and replace regularly
Avoid spicy or acidic foods
Avoid mouthwash that contains alcohol
May rinse with salt and baking soda after meals and at bedtime (1
cup warm water, ¼ tsp. baking soda, 1/8 tsp. salt) – Rinse & spit
• Remove and clean dentures well
• Use lip balm and keep mouth and lips moist
• Sip water or ice chips
(10)
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Taste Changes/Changes in Appetite
• Eat frequent small meals (5 or 6 small meals instead of 3 large
meals)
• Choose foods high in calories and protein
• If food has metallic taste, try plastic utensils
• Eat with friends/family
• Drink soups or milkshakes that are easy to swallow
• Food diary: Write down how much you eat and drink each day
Nausea & Vomiting
•
•
•
•
•
•
•

Eat small frequent meals for 24-48 hours after chemotherapy
Avoid spicy, fried, or fatty foods.
Avoid alcohol or acidic foods (orange, grapefruit, tomato)
Suck on ice chips or popsicles
Do not lie down right after eating
Take prescribed medications for nausea
May also use: Maalox, Mylanta, or TUMS for upset
stomach/indigestion
• Wait 40-60 minutes after taking nausea medications before eating
Diarrhea
• 4 or more loose watery stools in 1 day
• Drink 8-10 glasses of liquids daily (water, ginger ale, Gatorade,
decaffeinated tea, broth, jello)
• Use loperamide 4mg followed by 2mg every 4 hours: MAX 8 tabs in
1 day
• Follow the BRAT diet: bananas, rice, apple sauce, tea/toast
• Foods that may worsen diarrhea: Milk products, greasy/spicy foods,
caffeine, chocolate
• Herbs/supplements that may worsen diarrhea: magnesium, fish oil,
cat’s claw, garlic, flaxseed, high dose Vit C, aloe
• call office if diarrhea does not resolve in 24 hours
(11)
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Constipation
• Decrease in number of stools, hard or dry stools, straining
• Increase foods with fiber (vegetables, fruits, bran, raisins, whole grain
cereals)
• Add prunes or prune juice to diet
• Drink at LEAST 8 glasses water daily
• Increase exercise such as walking
• If no bowel movement in 2 days: Use a stool softener docusate
sodium (100-300mg/day) and Senna (2-6 tablets twice daily) increase
or decrease until you have a good bowel movement every 1-2 days.
• If bowels become loose stop the pills until more firm and start again
at lower dose
• May also take Milk of Magnesia 2-4 tsp. at bedtime
Pain
• Treatment may include Tylenol, Ibuprofen (if not contraindicated by
other conditions, check with your provider)
• Other prescription medications
Peripheral Neuropathy
•
•
•
•

•
•
•
•

Pain due to irritation of nerve endings in hands or feet
Burning, numbness, tingling or loss of coordination
Avoid extreme temperatures
If you are receiving oxaliplatin avoid cold temperatures or objects
for 5-7 days after treatment, may need to wear gloves to reach inside
refrigerator, drink room temperature or warm liquids
Don’t drink alcohol
Physical therapy may help with balance
May need prescription medications – ask your physician
Non-drug treatments: massage, physical therapy, acupuncture or
relaxation
(12)
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Hand-Foot Syndrome
• Known as palmar-plantar erythrodysesthesia
• Caused by some types of chemotherapy
• Signs include: Tingling, burning, redness, flaking, peeling, swelling,
rash, small sores or blisters, cracking
• Affects palms of hands and soles of feet
• Call physician or nurse
• Avoid direct sunlight or wear sunscreen
• Shower or baths in lukewarm water
• Mild soaps
• Apply mild creams: Udderly smooth, Bag Balm, Eucerin, Aveeno or
Lubriderm
• Apply antibiotic ointment if prescribed
• May be recommended to take Vitamin B6 100mg three times daily for
1 week, then 50mg three times daily until treatment is completed
Skin Conditions
•
•
•
•

Skin may become more sensitive
Rashes may develop
More sensitive to sun
Things that may help: Drink 8-10 glasses water daily, use mild soap
and lotions, use sunscreen, pat dry instead of rubbing, nail polish
may strengthen nails, keep nails short
• Call your doctor or nurse
Skin Conditions When Taking Targeted Therapy (EGFR)
• Examples of EGFR medications (Erbitux, Vectibix)
• Rash that may look like acne
• Red or inflamed skin
• Dry skin, cracks in skin, or crusting

(13)
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• Skin around nails tender, red and swollen
• Tips to help: mild soaps (Ivory, Dove, Aveeno), gentle moisturizer
(Udderly Smooth, Aveeno, Eucerin, Cetophil, Lubriderm), avoid sun
• Call your physician or nurse
Immune Therapy Common Side Effects
•
•
•
•

Examples of Immune Therapy (Opdivo, Keytruda, Imfinzi)
Skin reaction (redness, blistering, dryness)
Flu like symptoms (tired, chills, weakness, body aches)
Let your doctor or nurse know if you have any of the following:
a. New or worse cough
b. shortness of breath or chest pain
c. yellowing of the skin
d. severe nausea/vomiting
e. dark urine
f. diarrhea
g. blood in stools, dark stools, tarry stools
h. unusual headaches, changes in mood, confusion
i. blisters on skin or ulcers in the mouth

Birth Control and Sexuality
• Temporary or permanent infertility and sexual dysfunction may result
from chemotherapy
• Discuss concerns about sexual issues and fertility with your physician
or nurse
• Always use a method of birth control
• Females may use lubrication (Astroglide, Refresh or other nonhormonal lubricant) for vaginal dryness.

(14)
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Theoretical Framework
Mishel’s Theory of Uncertainty in Illness

•new balance
•new life view
•adjustment

•strategies
•information
gathering
•blocking/avoidance

•stimuli/diagnosis
•expectations
•coping/support
systems

Adaptation
to the illness

Antecedents
generating
uncertainty

Coping with
uncertainty

Appraisal of
uncertainty
•perception of illness
•threat vs.
opportunity
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Appendix G
Patient Satisfaction Survey Tool

Please circle the number that best fits your satisfaction with the education you
received about your chemotherapy treatment.
5 is the highest score; 1 is the lowest.
Did you feel you received enough information before starting your chemo?
5

4

3

2

1

Materials provided were easy for you to understand.
5

4

3

2

1

2

1

2

1

Enough time was spent on education.
5

4

3

You felt all your questions were addressed.
5

4

3

Please answer the following Yes or No
Did you call the triage nurse or come to the office with a concern about your
treatment?
Yes

No

Did you visit the Emergency Department, Urgent Care or Hospital for an emergent
issue regarding your treatment?
Yes
No
Other comments you would like to share about the educational process:
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
________________________________Thank you for your participation.
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Appendix H
Cost Analysis
Costs of proposal
1 RN/charge nurse

$36/hour

2 hours training

Printing costs
Estimated
patients/week
Estimated annual
cost

$0.42 per page
10

20 pages (estimate)
$8.40

$4368.00

Estimated cost of supportive care for one episode
Cost of Complete
Blood Count (CBC)
1-hour intravenous
infusion time
Each additional hour
Antiemetic (example
Zofran)
Steroid (example
Decadron)
1-liter normal saline
Total cost

$72.00 (one-time
cost)
$8.40
$84.00

1

$29.00

1

$187.00

1
8mg x 1

$81.00
$16.00

10mg x 1

$10.00

1

$6.00
$329.00

